Researchers are using brain scans, blood and spinal fluid to detect early signs of Alzheimer's disease. These "biomarkers" may also offer a quicker way to test new Alzheimer's drugs.
(Image credit: Courtesy of the National Institute on Aging/National Institutes of Health)
